Results 1 to 10 of about 1,994 (144)

Animal models of GM2 gangliosidosis: utility and limitations [PDF]

open access: yesThe Application of Clinical Genetics, 2016
Cheryl A Lawson,1,2 Douglas R Martin2,3 1Department of Pathobiology, 2Scott-Ritchey Research Center, 3Department of Anatomy, Physiology and Pharmacology, Auburn University College of Veterinary Medicine, Auburn, AL, USA Abstract: GM2 gangliosidosis, a ...
Douglas R Martin
exaly   +8 more sources

Genetics and Therapies for GM2 Gangliosidosis [PDF]

open access: yesCurrent Gene Therapy, 2018
Tay-Sachs disease, caused by impaired β-N-acetylhexosaminidase activity, was the first GM2 gangliosidosis to be studied and one of the most severe and earliest lysosomal diseases to be described. The condition, associated with the pathological build-up of GM2 ganglioside, has acquired almost iconic status and serves as a paradigm in the study of ...
Maria Begoña Cachón-González   +1 more
exaly   +5 more sources

Evaluation of the Landscape of Pharmacodynamic Biomarkers in GM1 and GM2 Gangliosidosis [PDF]

open access: yesClinical and Translational Science
GM1 and GM2 gangliosidosis are inherited, progressive, neurodegenerative lysosomal disorders of variable onset and disease progression. GM1 gangliosidosis is a result of biallelic pathogenic variants in the GLB1 gene, which confer absent or reduced β ...
Sydney Stern   +2 more
exaly   +3 more sources

Multimodal optical imaging and genetic features of AB variant GM2 gangliosidosis: a case report [PDF]

open access: yesFrontiers in Pediatrics, 2023
BackgroundAB variant GM2 gangliosidosis is an extremely rare autosomal recessive lysosomal storage disease. Macular cherry-red spots are the most commonly described ocular sign in this disease.
Qin Chen, Fang Lu
doaj   +2 more sources

Skeletal radiographic manifestations of GM2 gangliosidosis variant 0 (Sandhoff disease) in two Japanese domestic cats [PDF]

open access: yesJournal of Feline Medicine and Surgery Open Reports, 2022
Case series summary Two Japanese domestic cats with GM2 gangliosidosis variant 0, diagnosed at different times, are included in this case series. Both cats were diagnosed by genetic analysis and had the HEXB :c.667C>T pathogenic genetic variant, which ...
Yoshihiko Yu   +7 more
doaj   +2 more sources

Characterization of a phenotypically severe animal model for human AB-Variant GM2 gangliosidosis [PDF]

open access: yesFrontiers in Molecular Neuroscience, 2023
AB-Variant GM2 gangliosidosis (ABGM2) is a rare and lethal genetic disorder caused by mutations in the GM2A gene that lead to fatal accumulation of GM2 gangliosides (GM2) in neurons of the central nervous system (CNS).
Natalie M. Deschenes   +8 more
doaj   +2 more sources

Therapeutic advantages of combined gene/cell therapy strategies in a murine model of GM2 gangliosidosis [PDF]

open access: yesMolecular Therapy: Methods & Clinical Development, 2022
Genetic deficiency of β-N-acetylhexosaminidase (Hex) functionality leads to accumulation of GM2 ganglioside in Tay-Sachs disease and Sandhoff disease (SD), which presently lack approved therapies.
Davide Sala   +10 more
doaj   +2 more sources

GM2 Gangliosidosis AB Variant: A Hidden Truth. [PDF]

open access: yesCureus
GM2 gangliosidosis AB variant (GM2AB) is a rare neurodegenerative lysosomal storage disorder with clinical features resembling Tay-Sachs disease but characterized by normal lysosomal β-hexosaminidase A enzyme activity. To date, only 14 cases of the acute infantile form have been reported. To the best of our knowledge, this is the first case of GM2AB in
Noites I   +9 more
europepmc   +3 more sources

Novel bicistronic lentiviral vectors correct β-Hexosaminidase deficiency in neural and hematopoietic stem cells and progeny: implications for in vivo and ex vivo gene therapy of GM2 gangliosidosis

open access: yesNeurobiology of Disease, 2020
The favorable outcome of in vivo and ex vivo gene therapy approaches in several Lysosomal Storage Diseases suggests that these treatment strategies might equally benefit GM2 gangliosidosis.
Davide Sala   +2 more
exaly   +3 more sources

Biochemical characterization of the GM2 gangliosidosis B1 variant [PDF]

open access: yesBrazilian Journal of Medical and Biological Research, 2004
The deficiency of the A isoenzyme of ß-hexosaminidase (Hex) produced by different mutations of the gene that codes for the alpha subunit (Tay-Sachs disease) has two variants with enzymological differences: the B variant consists of the absence of Hex A ...
J.C. Tutor
doaj   +5 more sources

Home - About - Disclaimer - Privacy